» Articles » PMID: 27304511

CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction Through an SIRT3-Dependent Mechanism

Overview
Journal Cell Metab
Publisher Cell Press
Date 2016 Jun 16
PMID 27304511
Citations 401
Authors
Affiliations
Soon will be listed here.
Abstract

Nicotinamide adenine dinucleotide (NAD) levels decrease during aging and are involved in age-related metabolic decline. To date, the mechanism responsible for the age-related reduction in NAD has not been elucidated. Here we demonstrate that expression and activity of the NADase CD38 increase with aging and that CD38 is required for the age-related NAD decline and mitochondrial dysfunction via a pathway mediated at least in part by regulation of SIRT3 activity. We also identified CD38 as the main enzyme involved in the degradation of the NAD precursor nicotinamide mononucleotide (NMN) in vivo, indicating that CD38 has a key role in the modulation of NAD-replacement therapy for aging and metabolic diseases.

Citing Articles

Estropausal gut microbiota transplant improves measures of ovarian function in adult mice.

Kim M, Wang J, Pilley S, Lu R, Xu A, Kim Y bioRxiv. 2025; .

PMID: 40060387 PMC: 11888174. DOI: 10.1101/2024.05.03.592475.


CD38 mediates nicotinamide mononucleotide base exchange to yield nicotinic acid mononucleotide.

Madawala R, Banks J, Hancock S, Quek L, Turner N, Wu L J Biol Chem. 2025; 301(3):108248.

PMID: 39894219 PMC: 11903787. DOI: 10.1016/j.jbc.2025.108248.


SLC29A1 and SLC29A2 are human nicotinamide cell membrane transporters.

Chen M, Yuan L, Chen B, Chang H, Luo J, Zhang H Nat Commun. 2025; 16(1):1181.

PMID: 39885119 PMC: 11782521. DOI: 10.1038/s41467-025-56402-y.


NAD World 3.0: the importance of the NMN transporter and eNAMPT in mammalian aging and longevity control.

Imai S NPJ Aging. 2025; 11(1):4.

PMID: 39870672 PMC: 11772665. DOI: 10.1038/s41514-025-00192-6.


The role of metabolites in the progression of osteoarthritis: Mechanisms and advances in therapy.

Liu X, Zheng Y, Li H, Ma Y, Cao R, Zheng Z J Orthop Translat. 2025; 50:56-70.

PMID: 39868350 PMC: 11762942. DOI: 10.1016/j.jot.2024.10.003.


References
1.
Bai P, Canto C, Oudart H, Brunyanszki A, Cen Y, Thomas C . PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 2011; 13(4):461-468. PMC: 3086520. DOI: 10.1016/j.cmet.2011.03.004. View

2.
Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P . Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem. 2000; 276(4):2571-5. DOI: 10.1074/jbc.M006825200. View

3.
Beneke S, Scherr A, Ponath V, Popp O, Burkle A . Enzyme characteristics of recombinant poly(ADP-ribose) polymerases-1 of rat and human origin mirror the correlation between cellular poly(ADP-ribosyl)ation capacity and species-specific life span. Mech Ageing Dev. 2010; 131(5):366-9. DOI: 10.1016/j.mad.2010.04.003. View

4.
Shimazu T, Hirschey M, Hua L, Dittenhafer-Reed K, Schwer B, Lombard D . SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 2010; 12(6):654-61. PMC: 3310379. DOI: 10.1016/j.cmet.2010.11.003. View

5.
Prolla T, Denu J . NAD+ deficiency in age-related mitochondrial dysfunction. Cell Metab. 2014; 19(2):178-80. DOI: 10.1016/j.cmet.2014.01.005. View